Midlife Blood-Platelet Screening May Uncover Early Alzheimer’s Disease Risk
A groundbreaking study emerging from collaborations between The Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San...
Diana Fleming is a Scienmag editorial specialist profile for Neurodegenerative Diseases coverage.
A groundbreaking study emerging from collaborations between The Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San...
In a groundbreaking study published in Nature Communications, researchers have identified plasma phosphorylated tau217 (p-tau217) as a powerful biomarker for...
In the intricate landscape of Parkinson’s disease research, a startling new dimension has emerged—one that implicates environmental noise as a...
In a revolutionary advancement for neurodegenerative disease research, Answer ALS has announced the full public release of its groundbreaking ALS...
In a groundbreaking study that promises to reshape our understanding of neurodegenerative diseases, Zhao et al. (2025) delve deep into...
In the ongoing quest to unearth therapeutic strategies for Alzheimer’s disease, researchers have turned their attention to cathepsin B, a...
In a groundbreaking advancement poised to reshape Parkinson’s disease diagnostics, researchers have identified a synergistic blood-based biomarker duo, AP3B1 and...
In a groundbreaking new study published in Cell Death Discovery, researchers have uncovered a crucial link between the loss of...
In the intricate landscape of neurobiology, the relationship between oxidative stress and neurodegenerative diseases remains a focal point of research,...
In a groundbreaking study poised to reshape our understanding of amyotrophic lateral sclerosis (ALS), researchers have uncovered a critical cellular...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine